Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that Flex Pharma Co-founder and CEO, Christoph Westphal, M.D., Ph.D., has been appointed to the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. Dr. Westphal was Co-Founder, CEO and lead investor of Acceleron, Alnylam, Flex, Momenta, Sirtis and Verastem.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
